Iatrogenic botulism in a child with spastic quadriparesis

Journal of Child Neurology

Volumn 22, Issue 10, 2007, Pages 1235-1237

  Partikian, Arthur ^a   Mitchell, Wendy G ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse effects; Botulinum toxin; Botulism; Spasticity

Indexed keywords

ANTIBIOTIC AGENT; BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DIAZEPAM; TIZANIDINE; BOTULINUM TOXIN;

ARTICLE; ARTIFICIAL VENTILATION; BOTULISM; CASE REPORT; CLINICAL FEATURE; COUGHING; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FACIAL NERVE PARALYSIS; HUMAN; MALE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PTOSIS; QUADRIPLEGIA; SCHOOL CHILD; SLEEP APNEA SYNDROME; SPASTIC PARESIS; CHEMICALLY INDUCED DISORDER; CHILD; CONVALESCENCE; DISEASE COURSE; DRUG EFFECT; IATROGENIC DISEASE; LARYNX MUSCLE; PATHOPHYSIOLOGY; PHARYNX DISEASE; RESPIRATORY FAILURE; SKELETAL MUSCLE;

BOTULINUM TOXINS; BOTULISM; CHILD; DISEASE PROGRESSION; HUMANS; IATROGENIC DISEASE; LARYNGEAL MUSCLES; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PHARYNGEAL DISEASES; QUADRIPLEGIA; RECOVERY OF FUNCTION; RESPIRATORY INSUFFICIENCY; SLEEP APNEA SYNDROMES;

EID: 38149017820     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807306269     Document Type: Article

References (20)

1. Jankovic J. Dystonia: Medical therapy and botulinum toxin. Adv Neurol. 2004; 94:275-286.
2. Blitzer A. Botulinum toxin A and B: A comparative dosing study for spasmodic dysphonia. Otolaryngol Head Neck Surg. 2005; 133(6):836-838.
3. Dressler D., Eleopra R. Clinical use of non-A botulinum toxins: botulinum toxin type B. Neurotox Res. 2006; 9(2-3):121-125.
4. Jongerius PH, Rotteveel JJ, van Limbeek J., Gabreels Fjm, van Hulst K., van den Hoogen Fja. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004; 63(8):1371-1375.
5. Lenaerts ME Pharmacoprophylaxis of tension-type headache. Curr Pain Headache Rep. 2005; 9(6):442-447.
6. Schwerin A., Berweck S., Fietzek UM, Heinen F. Botulinum toxin B treatment in children with spastic movement disorders: A pilot study. Pediatr Neurol. 2004; 31(2):109-113.
7. Scott AB Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 1980; 17(1):21-25.
8. Silberstein S., Mathew N., Saper J., Jenkins S.; BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000; 40(6):445-450.
9. Arnon SS, Schechter R., Inglesby TV, et al. Botulinum toxin as a biological weapon: Medical and public health management. JAMA. 2001; 285(8):1059-1070.
10. Schantz EJ, Johnson EA Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev. 1992; 56(1):80-99.
11. Grumelli C., Verderio C., Pozzi D., Rossetto O., Montecucco C., Matteoli M. Internalization and mechanism of action of clostridial toxins in neurons. Neurotoxicology. 2005; 26(5):761-767.
12. Comella CL, Jankovic J., Shannon KM, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology. 2005; 65(9):1423-1429.
13. Beseler-Soto B., Sanchez-Palomares M., Santos-Serrano L., Landa-Rivera L., Sanantonio-Valdearcos F., Paricio-Talayero JM Iatrogenic botulism: A complication to be taken into account in the treatment of child spasticity [in Spanish]. Rev Neurol. 2003; 37(5):444-446.
14. Bhatia KP, Munchau A., Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dystonia: A report of three cases. J Neurol Neurosurg Psychiatry. 1999; 67(1):90-93.
15. Racette BA, Lopate G., Good L., Sagitto S., Perlmutter JS Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology. 2002; 59(9):1445-1447.
16. Tugnoli V., Eleopra R., Quatrale R., Capone JG, Sensi M., Gastaldo E. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol. 2002; 147(4):808-809.
17. Goldstein EM Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol. 2006; 21(3):189-192.
18. Rossi RP, Strax TE, Di Rocco A. Severe dysphagia after botulinum toxin B injection to the lower limbs and lumbar paraspinal muscles. Am J Phys Med Rehabil. 2006; 85(12):1011-1013.
19. Dressler D., Hallett M. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Eur J Neurol. 2006; 13(suppl1):11-15.
20. Molenaers G., Desloovere K., Fabry G., De Cock P. The effects of quantitative gait assessment and botulinum toxin A on musculoskeletal surgery in children with cerebral palsy. J Bone Joint Surg Am. 2006; 88(1):161-170.